America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Understand what to expect from financial planning and accounting services. Make informed decisions for your financial future.
23,685 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A federal court clears a $71 million ETH transfer on Arbitrum to Aave, but North Korea-linked creditors retain legal ...
New filings reveal a surge of political stock trading in Q1, prompting renewed calls for a ban on individual trades b...
Silver surged and fell in a wild year, turning SLV into a headline idea for investors. This guide walks through what ...
President Trump’s push for a temporary gas tax pause highlights a deeper funding crisis for roads and bridges. Expert...
Portugal and Austria won two Western seats on the U.N. Security Council, edging out Germany after a tight vote. The m...
Investors face a pivotal choice in 2026: M/I Homes versus Champion Homes. This guide breaks down how each builder ear...
Bitcoin remains in focus as investors weigh new geopolitical flare-ups. Markets are pricing risk as bitcoin (and peac...
Is Lilly stock undervalued healthcare? This article breaks down the valuation case, growth catalysts, risks, and a pr...
Long-term wealth isn’t built overnight. These dividend ETF picks could deliver steady income, steady growth, and the ...
Standard Chartered reaffirms a lofty Bitcoin target as Trump underscores China risk, pointing to crypto sovereignty a...
Prediction markets tied to the World Cup final surge to record volumes, with Spain favored over Argentina as betting ...